References

Citations

1. Longstreth GF, et al. (2006). Irritable bowel syndrome section of Functional bowel disorders. In DA Drossman et al., eds., Rome III: The Functional Gastrointestinal Disorders, 3rd ed., pp. 490–509. McLean, VA: Degnon Associates.

2. Talley NJ (2008). Functional gastrointestinal disorders: Irritable bowel syndrome, dyspepsia, and noncardiac chest pain. In L Goldman, D Ausiello, eds., Cecil Medicine, 23rd ed., pp. 990–998. Philadelphia: Saunders Elsevier.

3. American College of Gastroenterology Functional Gastrointestinal Disorders Task Force (2002). Evidence-based position statement on the management of irritable bowel syndrome in North America. American Journal of Gastroenterology, 97(11, Suppl): S1–S26.

4. Olden KW (2002). Diagnosis of irritable bowel syndrome. Gastroenterology, 122(6): 1701–1714.

5. Tack J (2006). Irritable bowel syndrome. In MM Wolfe et al., eds., Therapy of Digestive Disorders, 2nd ed., pp. 701–710. Philadelphia: Saunders Elsevier.

6. Brandt LJ, et al. (2002). Systematic review on the management of irritable bowel syndrome in North America. American Journal of Gastroenterology, 97(11, Suppl): S7–S26.

7. Spanier JA, et al. (2003). A systematic review of alternative therapies in the irritable bowel syndrome. Archives of Internal Medicine, 163(3): 265–274.

8. Liu JP, et al. (2006). Herbal medicines for treatment of irritable bowel syndrome. Cochrane Database of Systematic Reviews (1). Oxford: Update Software.

9. Lim B, et al. (2006). Acupuncture for treatment of irritable bowel syndrome. Cochrane Database of Systematic Reviews (4). Oxford: Update Software.

10. Sharara AI, et al. (2006). A randomized double-blind placebo-controlled trial of rifaximin in patients with abdominal bloating and flatulence. American Journal of Gastroenterology, 101(2): 326–333.

Other Works Consulted

• Chang I, et al. (2005). A dose-ranging, phase II study of the efficacy and safety of alosetron in men with diarrhea-predominant IBS. American Journal of Gastroenterology, 100(1): 115–123.

• Friedel D, et al. (2001). Ischemic colitis during treatment with alosetron. Gastroenterology, 120(2): 557–560.

• Spanier JA, et al., (2003). A systematic review of alternative therapies in the irritable bowel syndrome. Archives of Internal Medicine, 163: 265–274.

• Talley NJ (2006). Irritable bowel syndrome. In M Feldman et al., eds., Sleisenger and Fordtran's Gastrointestinal and Liver Disease, 8th ed., vol. 2, pp. 2633–2652. Philadelphia: Saunders Elsevier.